LES 2012 Spring Meeting

Licensing to Solve the Innovation Gap

The 2012 Spring Meeting is a highly targeted event that will focus primarily on the breaking developments and hot topics facing IP, licensing and business development professionals in the Life Sciences industry.

Welcome FiercePharma Readers!

Save $100 on the Spring Meeting! Register here using promo code FiercePharma.

Listen to an Interview with Keynote David Meeker, President & CEO of Genzyme

Meeker-DavidClick below to listen to this interview by Meeting Chair Mark Nawacki, where Dr. Meeker offers an inside look at how his company has leveraged strategic licensing and provides a preview of what we can expect at his talk in Boston next month.

If you prefer, you may download the interview audio file by clicking here.

Virtual Spring Meeting Sessions Now Available!

Couldn't make it to the LES Spring Meeting in Boston this year? We have you covered! Click here for details.

ENGAGE WITH INDUSTRY THOUGHT LEADERS DURING THESE FEATURED PLENARY SESSIONS:

Licensing to Solve the Innovation Gap

Speakers:
Daniel BehrSenior Vice President, Access BridgeGap Ventures 
Jeff EltonManaging DirectorAccenture
Robert S. Langer, David H. Koch Institute Professor, MIT

Keynote
Licensing as a Source of Innovation

Speaker:
David Meeker, President & CEO, Genzyme

Tales from the Trenches – a Spotlight on Deals in the News

Speakers:
Ariel D. JasieSenior Director, Business DevelopmentCelgene Corporation
Nagesh MahanthappaVP Corporate Development & OperationsAvila Therapeutics 
Michal PremingerExecutive Director of Office of Technology DevelopmentHarvard Medical School Office

*Please note: David Meeker is replacing George Scangos.